Other Financial Instruments. Unless otherwise provided for in the relevant Transaction Document concerning the Financial Instrument, the Reference Price for a Financial Instrument other than a Share will be the price or value of the Financial Instrument as reasonably determined by Macquarie in good faith having regard to the terms of the Financial Instrument.
Other Financial Instruments. The Trading Advisor may, from time to time, be eligible to invest the assets of the Company in assets to be listed on Appendix B hereto which may not be eligible for clearing through the Clearing Broker. Any such instruments, which may include, without limitation, swaps and treasury securities, will be bought and sold for the account in a manner consistent with industry practice using trading counterparties and/or custodians consented to by the Manager (such consent not to be unreasonably withheld) and such financial instruments shall be deemed to be held in the Clearing Broker Account for purposes of this Agreement.
Other Financial Instruments. We did not hold any forward exchange contracts at March 31, 2001. At December 31, 2000, we had forward foreign exchange contracts of approximately 2 months duration, to exchange euro and Belgian Francs for U.S. dollars in the total gross notional amount of $781,000. The net effect on settlement of these contracts during the three months ended March 31, 2001 was not material to our financial position or our results of operations and is included in other income (expense) in the accompanying consolidated statements of operations.
Other Financial Instruments. Financial instruments other than long-term indebtedness include cash and cash equivalents, accounts receivable and accounts payable. These instruments are recorded at book value, which we believe approximate their fair values due to their short term nature. In addition, as of March 4, 2017 and February 27, 2016, the Company has $6,874 and $6,069, respectively, of investments carried at amortized cost as these investments are being held to maturity. These investments are included as a component of prepaid expenses and other current assets as of March 4, 2017 and are included as a component of other assets as of February 27, 2016. The Company believes the carrying value of these investments approximates their fair value. The fair value for LIBOR-based borrowings under the Company’s senior secured credit facility and first and second lien term loans are estimated based on the quoted market price of the financial instrument which is considered Level 1 of the fair value hierarchy. The fair values of substantially all of the Company’s other long-term indebtedness are estimated based on quoted market prices of the financial instruments which are considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $7,263,378 and $7,556,599, respectively, as of March 4, 2017. The carrying amount and estimated fair value of the Company’s total long-term indebtedness was $6,914,483 and $7,235,916, respectively, as of February 27, 2016. There were no outstanding derivative financial instruments as of March 4, 2017 and February 27, 2016.
